Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kisspeptin in hypothalamic amenorrhea
NCT05633966Phase 1Completed
- Start
- Dec 2022
- Primary completion
- Aug 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of kisspeptin in hypothalamic amenorrhea (HA). Primary endpoint: Proportion of participants that achieve development of a mature follicle or show evidence of ovulation at 2 weeks. Started Dec 2022; status: completed.
02
Drugs
kisspeptin
03
Conditions
hypothalamic amenorrhea (HA)
Beyond the preview
Go deeper on NCT05633966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05633966.